Virus treatment for repeat C. difficile infection
Treatments studied
Part of Infections clinical trials.
This trial tests a virus-based treatment for people who have had C. difficile infection come back. The treatment is given as capsules and aims to stop the infection from returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had C. difficile infection come back at least once (first or second recurrence).
- You understand Danish.
- You do not have a serious food allergy that causes anaphylaxis.
- You can swallow capsules.
- You have not had a gastrointestinal perforation in the last 6 months.
- You have not had FMT or rectal bacteriotherapy in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called fecal microbiota transplantation (FMT), which puts healthy donor stool into your gut to help fight the bacteria that cause clostridium difficile infection. It may help clear the infection and restore your gut's natural balance.
This trial studies using a fecal microbiota transplant (FMT)—healthy gut bacteria moved from a screened donor—to help treat recurring or hard-to-control C. difficile infection. It may help restore a healthier gut environment when standard treatments keep failing or the infection returns.
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This trial studies whether fecal microbiota transplantation (a procedure that transfers healthy stool bacteria) can change a person’s gut bacteria after repeated C. difficile infection. It may help reduce recurring infections by restoring a healthier balance of gut microbes.
This Phase 1 study tests defined fecal microbiota (healthy gut bacteria) given to people with C. difficile diarrhea that didn’t go away or came back soon after antibiotics. It may help by restoring a healthier balance of gut bacteria so the infection can stop recurring.
Hear when a new Clostridium Difficile Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.